AstraZeneca, Bristol-Myers Squibb jointly launch diabetes drug

AstraZeneca, Bristol-Myers Squibb jointly launch diabetes drug

Mumbai: AstraZeneca Pharma India Ltd and the Indian arm of Bristol-Myers Squibb alliance has launched a type-II diabetes drug Saxagliptin in India, both the firms said in a joint statement on Thursday.

The pharma firms said the alliance will develop and commercialize two compounds discovered by Bristol-Myers Squibb for treatment of the type II diabetes, the joint statement said.

Close